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Abstract 
The presence of P2X7 on erythroid cells is well established, but its physiological role remains 
unclear. The current study aimed to determine if P2X7 activation induces reactive oxygen 
species (ROS) formation in murine erythroleukaemia (MEL) cells, a commonly used 
erythroid cell line. ATP induced ROS formation in a time- and concentration-dependent 
fashion. The most potent P2X7 agonist, 2'(3')-O-(4-benzoylbenzoyl)ATP, but not UTP or 
ADP, also induced ROS formation. The P2X7 antagonist, A-438079, impaired ATP-induced 
ROS formation. The ROS scavenger, N-acetyl-L-cysteine, and the ROS inhibitor, 
diphenyleneiodonium, also impaired P2X7-induced ROS formation, but use of 
enzyme-specific ROS inhibitors failed to identify the intracellular source of P2X7-induced 
ROS formation. P2X7-induced ROS formation was impaired partly by physiological 
concentrations of Ca2+ and Mg2+, and almost completely in cells in N-methyl-D-glucamine 
chloride medium. The p38 MAPK inhibitors SB202190 and SB203580, and the caspase 
inhibitor Z-VAD-FMK, but not N-acetyl-L-cysteine, impaired P2X7-induced MEL cell 
apoptosis. ATP also stimulated p38 MAPK and caspase activation, both of which could be 
impaired by A-438079. In conclusion, these findings indicate that P2X7 activation induces 
ROS formation in MEL cells and that this process may be involved in events downstream of 
P2X7 activation, other than apoptosis, in erythroid cells. 
 
Keywords: P2X7; extracellular ATP; red blood cell; reactive oxygen species; apoptosis 
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Introduction 
 
The P2X7 receptor is a trimeric ATP-gated cation channel that mediates the influx of 
extracellular Ca2+ and Na+, and efflux of intracellular K+, as well as the uptake of organic 
cations including N-methyl-D-glucamine+ (NMDG+) and fluorescent dyes such as ethidium+ 
[1]. P2X7 is expressed on haematopoietic, epithelial, bone and neuronal cells, where it 
functions in inflammation and immunity [2], and cellular homeostasis [3]. Due to these and 
other properties of P2X7 activation, this receptor plays important roles in health and disease 
[4]. The various biological roles attributed to P2X7 are the result of various signalling events 
downstream of P2X7 activation including reactive oxygen species (ROS) formation [5]. 
P2X7 activation induces ROS generation in a variety of cell types resulting in transcription 
factor activation [6], pro-inflammatory cytokine release [7, 8], microbial killing [9], cell 
death [10, 11] and autophagy [12]. However, it remains unknown if P2X7 activation can 
induce ROS formation in erythroid cells. 
The presence of P2X7 on erythroid cells is well established, but its physiological role 
remains unclear. P2X7 is present on mature red blood cells (erythrocytes) [13, 14] where it 
participates in cation fluxes [13, 15-17], cell death [16, 18-20]	  and the release of lipid-derived 
mediators [21]. P2X7 is also present on erythroid precursors including murine 
erythroleukaemia (MEL) cells [22, 23]. Our group directly demonstrated that MEL cells 
express P2X7, and that activation of this receptor induces the uptake of organic cations, rapid 
phosphatidylserine exposure, microparticle release and apoptosis in these cells [23]. In the 
current study, we demonstrate that P2X7 activation also induces ROS formation in MEL cells, 
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supporting a potential role for P2X7-induced ROS formation in intracellular signalling or 
oxidative stress in erythroid cells. 
 
Material and methods 
 
Reagents RPMI-1640 medium, L-glutamine, gentamicin and 2’,7’-dichlorodihydrofluorescein 
diacetate (H2DCFDA) were from Invitrogen (Grand Island, NJ, USA). FCS (heat inactivated 
before use) was from Lonza (Basel, Switzerland) or Bovogen Biologicals (East Kellior, 
Australia). ATP, 2'(3')-O-(4-benzoylbenzoyl)ATP (BzATP), ADP, UTP, rotenone, 
allopurinol, Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME), EGTA and 
BAPTA-AM were from Sigma Chemical Co (St Louis, MO, USA). A-438079 was from 
Tocris Bioscience (Ellisville, MO, USA). N-acetyl-L-cysteine (NAC) and 
7-aminoactinomycin D (7AAD) were from Alexis Biochemicals (Lausen, Switzerland). 
Diphenyleneiodonium (DPI) was from Cayman Chemical Company (Ann Arbor, MI, USA). 
Ethidium bromide was from Amresco (Solon, OH, USA). Apocynin and SB202190 were 
from Calbiochem (San Diego, CA, USA). Annexin-V-FLUOS and DNase I were from Roche 
Applied Science (Pensberg, Germany). SB203580 and Z-VAD-FMK were from Jena 
Bioscience (Jena, Germany) and BioVision (Mountain View, CA, USA), respectively. 
 
Cell culture MEL cells were maintained in complete culture medium (RPMI-1640 medium 
containing 10% FCS, 2 mM L-glutamine and 5 ng/ml gentamicin) as described [23]. 
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ROS formation measurements ATP-induced ROS formation was assessed in MEL cells 
loaded with H2DCFDA, which is converted to the fluorescent compound 
2',7'-dichlorofluorescein (DCF) upon oxidation by ROS. Briefly, MEL cells in NaCl medium 
(145 mM NaCl, 5 mM KCl, 5 mM D-glucose, 10 mM HEPES, pH 7.4) (1×106 cells/ml) were 
incubated with 5 µM H2DCFDA for 5 min at 37°C. Cells were centrifuged and washed once 
with NaCl medium. H2DCFDA-loaded cells in NaCl medium were incubated in the absence 
or presence of nucleotides (as indicated) at 37°C. Incubations were stopped by addition of an 
equal volume of ice-cold MgCl2 medium (145 mM NaCl, 5 mM KCl, 20 mM MgCl2, 10 mM 
HEPES, pH 7.4) and centrifugation. Cells were washed once with NaCl medium. The mean 
fluorescence intensity (MFI) of DCF fluorescence (ROS formation) was determined using a 
BD (San Diego, CA, USA) LSR II flow cytometer and FlowJo software (Tree Star, Ashland, 
OR, USA). 
In some experiments, ATP-induced ROS formation was assessed in cells pre-incubated 
in the absence or presence of different compounds (as indicated) at 37°C before the addition 
of ATP. In other experiments, ATP-induced ROS formation was assessed in cells in NaCl 
medium containing 2 mM CaCl2 and 1 mM MgCl2, KCl medium (150 mM KCl, 5 mM 
D-glucose, 10 mM HEPES, pH 7.4), N-methyl-D-glucamine chloride (NMDG Cl) medium 
(145 mM NMDG Cl, 5 mM KCl, 5 mM D-glucose, 10 mM HEPES, pH 7.4), complete 
culture medium, or in NaCl medium containing either 1 mM CaCl2, 100 µM EGTA or 1 mM 
Mg2+. Since free Ca2+ or Mg2+ can lower the concentration of ATP4-, cells in the presence of 
1 mM Ca2+ or 1 mM Mg2+ in some experiments were incubated with 1.54 or 1.74 mM ATP, 
respectively to provide equimolar ATP4- concentrations (415 µM) as calculated using the 
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Bound and Determined Program [24]. 
 
Ethidium+ uptake measurements P2X7-induced pore formation in MEL cells suspended in 
NaCl medium was assessed using a fixed-time ethidium+ uptake assay as described [23]. The 
MFI of ethidium+ uptake (pore formation) was determined by flow cytometry. In some 
experiments, ATP-induced ethidium+ uptake was assessed in cells pre-incubated with 
different compounds or incubated in different media as above (for ROS formation). 
 
Apoptosis measurements P2X7-induced apoptosis of MEL cells was performed as described 
[23]. Briefly, cells were pre-incubated in the absence or presence of different compounds (as 
indicated) at 37°C, followed by incubation in the absence or presence of 1 mM ATP for 24 h. 
Following ATP incubation, the percentage of Annexin-V+/7AAD− (early apoptotic) and 
Annexin-V+/7AAD+ (late apoptotic) cells was determined by flow cytometry. 
 
p38 MAPK activation measurements MEL cells in complete culture medium in 24-well plates 
(5×105 cells/ml/well) were pre-incubated in the absence or presence of 10 µM A-438079 for 
15 min at 37°C, followed by incubation in the absence or presence of 1 mM ATP for 5 min. 
Harvested cells were suspended in 100 µL ice-cold SDS sample buffer containing 5% 
2-mercaptoethanol, and sonicated in the presence of DNase I (10 µg/ml) for 5 min. Proteins 
were separated by SDS-PAGE (4% stacking and 10% resolving gels) and transferred to 
nitrocellulose membrane (Bio-Rad, Hercules, CA, USA). Immunoblotting of p38 MAPK and 
phospho-p38 MAPK was performed using the PhosphoPlus p38 MAPK (Thr180/Tyr182) 
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Antibody Kit (Cell Signaling Technology, Danvers, MA, USA) according to the 
manufacturer’s instructions. 
 
Caspase activation measurements Caspase activation was assessed using the CaspGLOW 
Fluorescein Active Caspase Staining Kit (BioVision) according to the manufacturer’s 
instructions. Briefly, MEL cells in complete culture medium in 24-well plates (5×105 
cells/ml/well) were pre-incubated in the absence or presence of 10 µM A-438079 for 15 min 
at 37°C, followed by incubation in the absence or presence of 1 mM ATP for 6 h. Following 
ATP incubation, cells were incubated with fluorescein isothiocyanate (FITC)-VAD-FMK for 
1 h at 37°C; 7AAD was added during the final 5 min of incubation. Cells were harvested and 
washed twice with Wash Buffer. The percentage of FITC+/7AAD+ (caspase activated) cells 
was determined by flow cytometry. 
 
Presentation of data and statistical analysis Results are presented as means ± SD. Data was 
compared using one-way analysis of variance (using Tukey's post test) or (when indicated) 
the unpaired two-tailed Student’s t-test using Prism 5 (GraphPad Software, San Diego, CA, 




P2X7 activation induces ROS formation in MEL cells To determine whether P2X7 activation 
can induce ROS formation in MEL cells, cells were loaded with with H2DCFDA, which is 
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converted to the fluorescent compound DCF upon oxidation by ROS. Cells in NaCl medium 
(nominally free of Ca2+ and Mg2+) were then incubated in the absence or presence of ATP for 
up to 30 mins, and the amount of ROS formation determined by flow cytometry. ATP 
induced ROS formation in MEL cells in a time-dependent fashion (Fig. 1A). Moreover, ATP 
induced ROS formation in a concentration-dependent fashion, with a maximal response at 2 
mM ATP and an EC50 of 151 µM (95% confidence interval of 120-190 µM) (Fig. 1B). This is 
similar to the EC50 for ATP-induced ethidium+ uptake in MEL cells [23] and for cation fluxes 
mediated by recombinant murine P2X7 [25]. 
To determine further if the ATP-induced ROS formation in MEL cells was mediated by 
P2X7 activation, cells were incubated in the absence or presence of the most potent P2X7 
agonist BzATP, or the non-P2X7 agonists ADP or UTP [25]; although it should be noted that 
BzATP also activates P2X1-P2X5 [26, 27]. ATP was included as a positive control. Both 
ATP and BzATP induced significant ROS formation in MEL cells compared to cells 
incubated in the absence of nucleotide (Fig. 1C). In contrast, ADP or UTP failed to induce 
ROS formation (Fig. 1C). Finally, to confirm that ATP-induced ROS formation was mediated 
by P2X7 activation, MEL cells were pre-incubated in the absence or presence of the P2X7 
antagonist A-438079, before incubation in the absence or presence of ATP. As above (Fig. 
1A-C), ATP induced significant ROS formation in MEL cells compared to cells incubated in 
the absence of ATP (Fig. 1D). Pre-incubation of MEL cells with 10 µM A-438079 impaired 
ATP-induced ROS formation by 87 ± 1% (Fig. 1D). Collectively, these results indicate that 
extracellular ATP induces ROS formation in MEL cells by P2X7 activation. 
The above studies were conducted with MEL cells suspended in NaCl medium 
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nominally free of Ca2+ and Mg2+. Therefore, to assess if ATP could induce ROS formation in 
MEL cells in medium containing physiological concentrations of divalent cations, MEL cells 
were suspended in NaCl medium containing 2 mM Ca2+ and 1 mM Mg2+, and the 
ATP-induced ROS formation was assessed. Due to the known inhibitory actions of Ca2+ and 
Mg2+ on P2X7 [28, 29], cells were exposed to 1 mM ATP (as above), as well as 2 and 3 mM 
ATP. ATP induced ROS formation in MEL cells in NaCl medium (containing physiological 
concentrations of divalent cations) in a concentration-dependent fashion (Fig. 1E). 
 
P2X7-induced ROS formation in MEL cells is impaired by NAC and DPI To confirm that 
P2X7 activation induced ROS formation in MEL cells, cells in NaCl medium (nominally free 
of Ca2+ and Mg2+) were pre-incubated in the absence or presence of the ROS scavenger NAC, 
or in the presence of DMSO diluent control or the broad-spectrum ROS inhibitor DPI before 
incubation in the absence or presence of ATP. As above (Fig. 1), ATP induced significant 
ROS formation in MEL cells compared to cells incubated in the absence of ATP (Fig. 2A,B). 
Pre-incubation of MEL cells with 10 mM NAC or 20 µM DPI impaired ATP-induced ROS 
formation by 70 ± 7% and 50 ± 15%, respectively (Fig. 2A,B). To determine if NAC or DPI 
directly affected P2X7, ATP-induced ethidium+ uptake was measured in the absence or 
presence of each compound. Pre-incubation of MEL cells with NAC or DPI (as above) did 
not alter the amount of ATP-induced ethidium+ uptake (Fig. 2A,B). 
ROS can be generated from numerous sources within cells. Therefore, in an attempt to 
identify the intracellular source of ROS generated downstream of P2X7 activation, MEL cells 
in NaCl medium (nominally free of Ca2+ and Mg2+) were pre-incubated in the presence of 
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diluent control (as indicated), or apocynin, rotenone, allopurinol or L-NAME, which impair 
NADPH oxidase, mitochondrial complex I, xanthine oxidase or nitric oxide synthase, 
respectively, before incubation in the absence or presence of ATP. Pre-incubation times and 
antagonist concentrations were based on previous studies with murine macrophages [10, 11]. 
Again, ATP induced significant ROS formation in MEL cells compared to cells incubated in 
the absence of ATP (Fig. 2C-F). Pre-incubation of MEL cells with either 100 µM apocynin, 5 
µM rotenone, 100 µM allopurinol or 1 mM L-NAME had no significant effect on 
ATP-induced ROS formation compared to cells incubated with both the respective diluent 
control and ATP (Fig. 2C-F). In the absence of ATP, ROS formation in the presence of 
apocynin, allopurinol or L-NAME was not significantly different to the respective diluent 
control (Fig. 2C,E,F). In contrast, in the absence of ATP, rotenone induced significant ROS 
formation compared to DMSO (Fig. 2D). Shorter (45 min) incubations with different 
concentrations of rotenone in the absence of ATP also induced ROS formation in MEL cells 
in concentration-dependent fashion, with significant ROS formation observed with a 
minimum of 0.5 µM rotenone and with an EC50 of >2 µM (results not shown). While 30 min 
pre-incubation of MEL cells with 0.1 µM rotenone potentiated ATP-induced ROS formation 
compared to cells incubated with both DMSO and ATP (results not shown). Pre-incubation of 
MEL cells with either apocynin, rotenone, allopurinol or L-NAME (as above) had no 
significant effect on ATP-induced ethidium+ uptake compared to cells incubated with both 
the respective diluent control and ATP (Fig. 2C-F). 
 
P2X7-induced ROS formation is impaired in MEL cells in NaCl medium containing Ca2+ or 
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Mg2+, or in NMDG Cl medium P2X7 is a trimeric ATP-gated cation channel [1], therefore a 
series of experiments were undertaken to explore a possible role for divalent or monovalent 
cations in P2X7-induced ROS formation. For each experiment, cells in different media were 
compared to cells in NaCl medium (nominally free of Ca2+ and Mg2+). P2X7-induced ROS 
formation is dependent on Ca2+ influx in rat, but not murine, submandibular gland cells [30, 
31]. Therefore, to determine if P2X7-induced ROS formation in MEL cells is dependent on 
Ca2+ influx, ATP-induced ROS formation was compared in cells in the absence or presence 
of additional Ca2+. ATP induced significant ROS formation in MEL cells in either the 
absence or presence of 1 mM Ca2+ compared to similarly treated cells incubated in the 
absence of ATP (Fig. 3A). Of note, ATP-induced ROS formation was significantly lower in 
the presence of Ca2+ compared to ATP-induced ROS formation in the absence of Ca2+ (Fig. 
3A). This result paralleled observations with ATP-induced ethidium+ uptake, with 
ATP-induced ethidium+ uptake significantly lower in the presence of Ca2+ compared to 
ATP-induced ethidium+ uptake in the absence of Ca2+ (Fig. 3A). 
NaCl medium may contain nominal amounts of Ca2+. Therefore, to further exclude a role 
for Ca2+ influx in P2X7-induced ROS formation, ATP-induced ROS formation was compared 
in MEL cells in the absence or presence the Ca2+ chelator EGTA. ATP induced significant 
ROS formation in MEL cells in either the absence or presence of 100 µM EGTA compared to 
similarly treated cells incubated in the absence of ATP (Fig. 3B). Moreover, ATP-induced 
ethidium+ uptake was similar in MEL cells in either the absence or presence of EGTA (Fig. 
3B) indicating that neither EGTA nor nominal amounts of extracellular Ca2+ had a direct 
effect on P2X7-induced pore formation. 
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Next, the potential role of intracellular Ca2+ increase in P2X7-induced ROS formation in 
MEL cells was examined by comparing ATP-induced ROS formation in MEL cells 
pre-incubated in the presence of DMSO or the intracellular Ca2+ chelator BAPTA-AM. ATP 
induced significant ROS formation in MEL cells in either the presence of DMSO or 10 µM 
BAPTA-AM compared to similarly treated cells incubated in the absence of ATP (Fig. 3C). 
Moreover, ATP-induced ethidium+ uptake was similar in MEL cells in either the presence of 
DMSO or BAPTA-AM (Fig. 3C) indicating that neither BAPTA-AM nor intracellular Ca2+ 
increase had a direct effect on P2X7-induced pore formation. 
Since the current study predominately assessed P2X7-induced ROS formation in MEL 
cells in NaCl medium, which may contain nominal amounts of Mg2+, the possibility remained 
that this process was dependent on Mg2+ efflux. Therefore, ATP-induced ROS formation was 
compared in cells in the absence or presence of 1 mM Mg2+, a concentration similar to that of 
free intracellular Mg2+. ATP induced significant ROS formation in MEL cells in either the 
absence or presence of Mg2+ compared to similarly treated cells incubated in the absence of 
ATP (Fig. 3D). As above for Ca2+ (Fig. 3A), ATP-induced ROS formation was significantly 
lower in the presence of Mg2+ compared to ATP-induced ROS formation in the absence of 
Mg2+ (Fig. 3D). This result paralleled observations with ATP-induced ethidium+ uptake, with 
ATP-induced ethidium+ uptake significantly lower in the presence of Mg2+ compared to 
ATP-induced ethidium+ uptake in the absence of Mg2+ (Fig. 3D). 
Both ROS formation and K+ efflux are involved in P2X7-induced interleukin-1β release 
from monocytes, although it remains to be determined if these upstream processes are linked 
[32]. Therefore, to determine if P2X7-induced ROS formation in MEL cells is dependent on 
	  
	   13	  
K+ efflux, ATP-induced ROS formation was compared in cells in NaCl medium and KCl 
medium, which prevents the loss of intracellular K+. The amount of ATP-induced ROS 
formation in MEL cells in KCl medium was similar to ROS formation in cells in NaCl 
medium (Fig. 3E). To determine if the inability of high extracellular K+ to impair 
ATP-induced ROS formation was not due to altered P2X7 function in KCl medium, 
ATP-induced ethidium+ uptake was assessed in cells in both media. ATP-induced ethidium+ 
uptake was similar in MEL cells incubated in either medium (Fig. 3E). 
The above results with KCl medium (Fig. 3E) indirectly exclude a role for Na+ influx in 
P2X7-induced ROS formation in MEL cells. It is well known however that high 
concentrations of extracellular K+ will depolarise cells and interfere with various transport 
systems. Therefore, ATP-induced ROS formation was compared in cells in NaCl medium and 
NMDG Cl medium, which is nominally free of Na+. Both media were nominally free of Ca2+ 
and Mg2+. In contrast to observations with KCl medium above (Fig. 3E), ATP-induced ROS 
formation was impaired by 88 ± 1% in MEL cells in NMDG Cl medium compared to cells in 
NaCl medium (Fig. 3F). To determine if this inhibition was due to impaired P2X7 function in 
NMDG Cl medium, ATP-induced ethidium+ uptake was assessed in cells in both media. In 
contrast to ROS formation, ATP-induced ethidium+ uptake was approximately two-fold 
greater in MEL cells incubated in NMDG Cl medium compared to cells in NaCl medium (Fig. 
3F). 
 
p38 MAPK and caspase activation, but not ROS formation, mediates P2X7-induced apoptosis 
of MEL cells Our group previously demonstrated that P2X7 activation induces apoptosis of 
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MEL cells [23], however the intracellular signalling pathways involved were not determined. 
ROS formation, as well as the p38 MAPK and caspase pathways are involved in 
P2X7-induced apoptosis of RAW264.7 macrophages [10]. Therefore, the roles of these 
pathways in P2X7-induced MEL cell apoptosis were examined. First, cells were 
pre-incubated in the absence or presence of NAC before incubation in the absence or 
presence of ATP. As previously observed [23], incubation of MEL cells with 1 mM ATP 
induced a significant increase in the percentage of Annexin-V+/7AAD− (early apoptotic) and 
Annexin-V+ /7AAD+ (late apoptotic) cells (Fig. 4A). Pre-incubation of MEL cells with 10 
mM NAC failed to impair ATP-induced early or late apoptosis (Fig. 4A). Moreover, 
incubation of MEL cells in complete culture medium with 1 mM ATP (as used in the 
apoptosis assay) did not induce significant ROS formation despite 1 mM ATP causing 
significant ROS formation in MEL cells in NaCl medium (nominally free of Ca2+ and Mg2+) 
(Fig. 4B). 
Next, cells were pre-incubated in the presence of DMSO or the p38 MAPK inhibitors 
SB202190 or SB203580 before incubation in the absence or presence of ATP. Again ATP 
induced a significant increase in early and late apoptotic cells (Fig. 4C). Pre-incubation of 
MEL cells with 20 µM SB202190 significantly impaired ATP-induced early and late 
apoptosis by 56 ± 5% and 56 ± 9%, respectively (Fig. 4C). Similarly, pre-incubation of MEL 
cells with 20 µM SB203580 impaired the amount of ATP-induced early and late apoptosis by 
48 ± 17% and 52 ± 6%, respectively (Fig. 4C). 
Next, cells were pre-incubated in the presence of DMSO, or the broad-spectrum caspase 
inhibitor Z-VAD-FMK before incubation in the absence or presence of ATP. Again ATP 
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induced a significant increase in early and late apoptotic cells (Fig. 4D). Pre-incubation of 
MEL cells with 20 µM Z-VAD-FMK significantly impaired the amount of ATP-induced late 
apoptotic cells by 36 ± 2% (Fig. 4D). In contrast, pre-incubation of cells with Z-VAD-FMK 
failed to impair the amount of early apoptotic cells induced by ATP (Fig. 4D). 
p38 MAPK and caspase inhibitors have been reported to impair P2X7-induced pore 
formation [33, 34]. To exclude the possibility that the above compounds impaired 
P2X7-induced apoptosis of MEL cells by directly inhibiting P2X7, cells were pre-incubated 
in the presence of DMSO, SB202190, SB203580 or Z-VAD-FMK (as above), and the 
P2X7-induced ethidium+ uptake assessed. ATP induced significant ethidium+ uptake into 
MEL cells compared to cells incubated in the absence of ATP (Fig. 4E). Pre-incubation of 
MEL cells with any of the compounds failed to alter the amount of ATP-induced ethidium+ 
uptake (Fig. 4E). Collectively, these results indicate that p38 MAPK and caspase activation, 
but not ROS formation, are involved in P2X7-induced apoptosis of MEL cells. 
 
P2X7 activation induces p38 MAPK and caspase activation in MEL cells To support the role 
of p38 MAPK activation in the P2X7-induced apoptosis of MEL cells, ATP-induced p38 
MAPK phosphorylation was examined by immunoblotting. Immunoblotting with an 
anti-phospho-p38 MAPK antibody revealed that incubation of cells with ATP for 5 min 
induced greater amounts of p38 MAPK activation compared to cells incubated in the absence 
of ATP (Fig. 5A). Moreover, pre-incubation of cells with the P2X7 antagonist A-438079 (10 
µM) impaired the amount ATP-induced p38 activation compared to ATP alone (Fig. 5A). 
To support the role of caspase activation in the P2X7-induced apoptosis of MEL cells, 
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ATP-induced caspase activity was examined using a FITC-conjugated caspase substrate and 
flow cytometry. MEL cells were incubated in the absence or presence of ATP for 6 h, and 
then for a further 1 h with FITC-VAD-FMK and the percentage of FITC+/7AAD+ cells 
(caspase activation) measured by flow cytometry. Incubation of cells with ATP resulted in a 
2.6-fold increase in the relative percentage of cells with activated caspases compared to cells 
incubated in the absence of ATP (Fig. 5B). Pre-incubation of cells with 10 µM A-438079 
impaired the amount ATP-induced caspase activation by 95 ± 9% compared to cells 
incubated with ATP alone (Fig. 5B). Collectively, these results indicate that P2X7 activation 
stimulates p38 MAPK and caspases, and indirectly supports a role for these enzymes in the 




The current study demonstrates that P2X7 activation results in the formation of ROS in MEL 
cells, an erythroid cell line. P2X7-induced ROS formation has been previously observed in 
myeloid cells [6-12, 35], glomerular mesangial cells [36] and submandibular gland cells [30, 
31], but to the best of our knowledge the current study is the first to demonstrate that P2X7 
activation causes ROS formation in erythroid cells. It will be of future importance to 
determine if P2X7 induces ROS formation in primary erythroid cells. Moreover, it will be 
important to identify the intracellular source of ROS formation downstream of P2X7 
activation in erythroid cells. In the current study, use of apocynin, rotenone, allopurinol and 
L-NAME, which impair NADPH oxidase, mitochondrial complex I, xanthine oxidase and 
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nitric oxide synthase, respectively, failed to identify the intracellular source of P2X7-induced 
ROS formation in MEL cells; however the mitochondrial respiratory chain cannot be 
excluded as a source. Although rotenone is commonly used as an inhibitor of mitochondrial 
ROS formation, it has been widely reported to also induce mitochondrial ROS formation [37]. 
Consistent with the latter, rotenone repeatedly increased basal ROS formation in MEL cells, 
making it difficult to ascertain if mitochondria were the source of P2X7-induced ROS 
formation. Moreover, DPI can impair mitochondrial ROS formation, as well as NADPH 
oxidase ROS formation [38], supporting a possible role for mitochondria in P2X7-induced 
ROS formation. The failure of apocynin to impair P2X7-induced ROS formation excludes a 
role for NADPH oxidase in this process; however further studies using gene knockdown 
approaches are required to support this conclusion. Nevertheless based on the current results, 
the mitochondrial respiratory chain or enzyme systems other than those examined in the 
current study remain the most likely sources of P2X7-induced ROS formation in erythroid 
cells. 
The physiological role of P2X7-induced ROS formation in erythroid cells remains to be 
established. Accumulating evidence suggests that ROS are involved in cell homeostasis, 
proliferation, differentiation and death [39, 40]. Specifically in relation to erythroid cells, low 
amounts of ROS are involved in the differentiation of erythroid progenitors, through 
interactions with FoxO3 and other transcription factors [41]. Whereas, excess amounts of 
ROS may shorten the life-span of mature erythroid cells [41]. In the current study however, 
the presence of the ROS scavenger NAC failed to impair P2X7-induced apoptosis of MEL 
cells, suggesting that P2X7-induced ROS formation is more likely to be involved in 
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signalling events related to erythroid cell homeostasis, proliferation or differentiation rather 
than erythroid cell death. An alternative, but not mutually exclusive, concept is that 
P2X7-induced ROS formation may result in phosphatidylserine exposure (in the absence of 
immediate cell death) and the subsequent removal of erythroid precursors from the 
circulation in certain disease states such as thalassaemia. In this regard, thalassaemic 
DNA-containing reticulocytes and erythrocytes have a higher content of ROS and exposed 
phosphatidylserine compared to DNA-free counterparts, leading the authors to postulate that 
oxidative stress-induced phosphatidylserine exposure is involved in the clearance of these 
cells from the circulation [42]. 
The current study demonstrates that Na+ influx but not K+ efflux may have a role in 
P2X7-induced ROS formation in MEL cells. NMDG Cl medium, which is nominally free of 
Na+, almost completely impaired P2X7-induced ROS formation, however KCl medium, 
which is also nominally free of Na+, did not. These conflicting results may be explained by at 
least two, but not mutually exclusive, possibilities. First, since P2X7 activation can induce 
NMDG+ uptake [43], the possibility remains that P2X7-induced ROS formation is impaired 
by increased intracellular NMDG+ rather than through the absence of Na+ influx. Second, 
since high concentrations of extracellular K+ can depolarise cells and interfere with various 
transport systems, the possibility remains that under these (KCl medium) but not other 
conditions (NaCl medium) that Na+ influx is not essential for P2X7-induced ROS formation. 
Reports for a role for Na+ influx in P2X7-induced signalling events are few, however others 
have shown that Na+ influx is involved in P2X7-induced rapid exposure of 
phosphatidylserine in murine thymocytes [44] and P2X7-induced mitochondrial membrane 
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depolarisation in rat submandibular glands [45]. Thus, the current study may offer another 
example of the importance of Na+ influx in a P2X7-induced signalling event. In contrast, this 
study indicates that K+ efflux is not essential for P2X7-induced ROS formation in MEL cells. 
Both ROS formation and K+ efflux are involved in P2X7-induced interleukin-1β from 
monocytes, although it remains unknown if these upstream processes are linked [32]. The 
absence of a role for K+ efflux in P2X7-induced ROS formation in MEL cells suggests that 
K+ efflux and ROS formation may be involved in distinct pathways in monocyte 
interleukin-1β release downstream of P2X7 activation. 
The current study also demonstrates that Ca2+ influx or Mg+ efflux, or an increase in 
intracellular Ca2+ is not essential for P2X7-induced ROS formation in MEL cells. Others 
have shown that P2X7-induced ROS formation is dependent on Ca2+ influx in rat, but not 
murine, submandibular gland cells [30, 31]. Thus, the current study with a murine erythroid 
cell line parallel those of murine submandibular gland cells. Of note however, 1 mM 
extracellular Ca2+ or Mg2+, but not nominal concentrations of extracellular Ca2+ (as observed 
with the use of EGTA), impaired both P2X7-induced ROS formation and pore formation in 
MEL cells despite the presence of equivalent ATP4- concentrations. This suggests that mM 
(or perhaps µM) concentrations of extracellular Ca2+ and Mg2+ may act as allosteric inhibitors 
of murine P2X7 as originally observed for rat P2X7 [46], and established by more recent 
studies of rat P2X7 [28, 29]. The current study also demonstrates that an increase in 
intracellular Ca2+ is not essential for P2X7-induced ROS formation (and pore formation) in 
MEL cells. To the best of our knowledge the potential role of intracellular Ca2+ on 
P2X7-induced ROS formation in any cell type has not been reported, although others have 
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excluded a role for an increase in intracellular Ca2+ in ATP-induced organic cation uptake 
into RAW264.7 macrophages and HEK-293 cells transfected with rat P2X7 [47]. 
The current study confirms that P2X7 activation induces apoptosis of MEL cells, and 
demonstrates for the first time that this process involves activation of p38 MAPK and 
caspases, but not ROS formation. The involvement of p38 MAPK and caspase activation in 
P2X7-induced MEL cell apoptosis parallels observations with P2X7-induced apoptosis of 
RAW264.7 cells [10]. In contrast, this previous study also demonstrated a role for ROS 
formation in RAW264.7 cell apoptosis, which was not required for MEL cell apoptosis in the 
current study. This difference was not due to impaired scavenger action of NAC, as this 
compound impaired P2X7-induced ROS formation in MEL cells. Collectively, the above 
indicates that p38 MAPK and caspase activation, and ROS formation are independent 
processes downstream of P2X7 activation in MEL cells. Although the current study 
demonstrated that caspase activation mediates the P2X7-induced apoptosis of MEL cells, the 
identity of the caspases involved remains unknown. Others have shown that high 
pressure-induced apoptosis of MEL cells involves both the extrinsic and intrinsic pathways 
mediated by caspase-8 and caspase-9, respectively, as well as the downstream activation of 
caspase-3 [48, 49]. Thus, it is likely that either or both caspase-8 and caspase-9, as well as 
caspase-3 are involved in P2X7-induced MEL cell apoptosis. 
The physiological role of P2X7-induced apoptosis of erythroid cells, as well as other cell 
types remains poorly defined. Studies of P2X7-deficient mice suggest that the P2X7 is not 
involved in regulating cell numbers under normal, physiological conditions [50, 51], except 
in bone homeostasis [52] and the peripheral T cell compartment [53]. Nevertheless 
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P2X7-induced apoptosis remains a well-described event [2, 3]. Therefore, it is likely that 
P2X7-induced apoptosis may play a role in removing damaged erythroid cells to prevent the 
development of anaemia or leukaemia [54], or to promote their rapid clearance from the 
circulation to prevent autoimmunity [55]. Alternatively, errant ATP release and subsequent 
P2X7-induced apoptosis of erythroid progenitors may be associated with the premature loss 
of these cells to cause anaemia [54]. This may be particular relevant to chemotherapy, which 
can cause the release of ATP from cells [56] and induce cytotoxicity in immature erythroid 
progenitors to cause anaemia in cancer patients [57]. 
Finally, the current study demonstrates that neither the ROS scavenger (NAC) nor any of 
the ROS inhibitors (DPI, apocynin, rotenone, allopurinol and L-NAME) had a direct effect on 
P2X7 itself. The inability of these compounds to impair P2X7-induced pore formation in 
MEL cells is consistent with similar findings in murine J774 cells and primary murine 
macrophages [11]. Thus, these observations validate the current and future use of these 
compounds to study ROS formation downstream of P2X7 activation, and indicate that ROS 
formation does not modulate P2X7-induced pore formation. In contrast, P2X7 in some cell 
types or studies can be directly impaired by a number of enzyme inhibitors [33, 34, 58-60]. 
Of relevance to the current study, the p38 MAPK inhibitors SB202190 or SB203580 can 
impair P2X7-induced pore formation in human THP-1 myeloid cells, murine 2BH4 thymic 
epithelial cells and primary murine macrophages [33, 34]. Although others have 
demonstrated that these compounds impair ATP-induced pore formation mediated by human, 
but not rat or murine, recombinant P2X7 [61]. This latter finding is consistent with the 
absence of an inhibitory effect of SB202190 or SB203580 on P2X7-induced pore formation 
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in MEL cells. The caspase-1 and caspase-3 inhibitors YVAD and DEVD, respectively have 
also been shown to impair P2X7-induced pore formation in THP-1 cells [33]. However, the 
broad-spectrum caspase inhibitor Z-VAD-FMK failed to impair P2X7-induced pore 
formation in MEL cells.  
In conclusion, these findings indicate that P2X7 activation induces ROS formation in 
MEL cells and that this process may be involved in events downstream of P2X7 activation, 
other than apoptosis, in erythroid cells. This study highlights the potential role of P2X7 
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Figure legends 
 
Fig. 1 P2X7 activation induces ROS formation in MEL cells. H2DCFDA-loaded MEL cells 
in (A-D) NaCl medium or (E) NaCl medium (containing 2 mM Ca2+ and 1 mM Mg2+) were 
incubated at 37°C in the absence (Basal) or presence of (A) 1 mM ATP for up to 30 min, (B) 
varying ATP concentrations for 15 min, (C) 1 mM ATP, UTP or ADP, or 200 µM BzATP for 
15 min, (D) 10 µM A-438079 for 15 min, and then in the absence or presence of 1 mM ATP 
for 15 min, or (E) 1, 2 or 3 mM ATP for 15 min. (A-E) Incubations were stopped by addition 
of MgCl2 medium and centrifugation, and the mean fluorescence intensity (MFI) of DCF 
(ROS formation) was determined by flow cytometry. ROS formation is expressed as (A and 
C-E) MFI or (B) percentage of maximum response compared to 2 mM ATP. Results are 
mean ± SD (A and C-E, n = 3; B, n = 6); where the SD is not visible, SD is ≤ 2.6; *P < 0.05, 
**P < 0.01 compared to corresponding Basal; ††P < 0.01 compared to ATP alone (C and D, 
ANOVA; E, Student’s t-test). 
 
Fig. 2 P2X7-induced ROS formation in MEL cells is impaired by NAC and DPI. 
H2DCFDA-loaded MEL cells (left panels) or MEL cells (right panels) in NaCl medium were 
pre-incubated at 37°C in the (A, F) absence (Control), or presence of (A) 10 mM NAC for 30 
min or (F) 1 mM L-NAME for 60 min, or in the presence of (B) DMSO or 20 µM DPI for 30 
mins, (C) DMSO or 100 µM apocynin for 60 mins, (D) DMSO or 5 µM rotenone for 60 mins, 
or (E) NaOH or 100 µM allopurinol for 30 mins. (A-F) Cells were then incubated in the 
absence (Basal) or presence of 1 mM ATP at 37°C for 15 min; 25 µM ethidium+ was also 
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present (right panels). Incubations were stopped by addition of MgCl2 medium and 
centrifugation, and the mean fluorescence intensity (MFI) of DCF (ROS formation; left 
panels) or ethidium+ uptake (pore formation; right panels) analysed by flow cytometry. 
Results are mean ± SD (n = 3); *P < 0.05, **P < 0.01 compared to corresponding Basal; ††P 
< 0.01 compared to ATP without NAC or antagonist; ‡‡P < 0.01 compared to Basal control. 
 
Fig. 3 P2X7-induced ROS formation is impaired in MEL cells in NaCl medium containing 
Ca2+ or Mg2+, or in NMDG Cl medium. H2DCFDA-loaded MEL cells (left panels) or MEL 
cells (right panels) in (A, B and D) NaCl medium in the absence (Control) or presence of (A) 
1 mM Ca2+, (B) 100 µM EGTA or (D) 1 mM Mg2+, (C) NaCl medium in the presence of 
DMSO or 10 µM BAPTA-AM (pre-incubated at 37°C for 30 min), (E) NaCl or KCl medium, 
or (F) NaCl or NMDG Cl medium were incubated in the absence (Basal) or presence of 415 
µM ATP4- (1, 1.54 or 1.74 mM ATP as explained in Materials and methods) at 37°C for 15 
min; 25 µM ethidium+ was also present (right panels). (A-F) Incubations were stopped by 
addition of MgCl2 medium and centrifugation, and the mean fluorescence intensity (MFI) of 
DCF (ROS formation; left panels) or ethidium+ uptake (pore formation; right panels) 
analysed by flow cytometry. Results are mean ± SD (n = 3); *P < 0.05, **P < 0.01 compared 
to corresponding Basal; †P < 0.05, ††P < 0.01 compared to ATP alone; ‡‡P < 0.01 compared 
to Basal control. 
 
Fig. 4 p38 MAPK and caspase activation, but not ROS formation, mediates P2X7-induced 
apoptosis in MEL cells. (A, C and D) MEL cells in complete culture medium were 
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pre-incubated at 37°C for 30 min (A) in the absence (Control) or presence of 10 mM NAC, in 
the presence of (C) DMSO, 20 µM SB202190 or 20 µM SB203580, or (D) DMSO or 20 µM 
Z-VAD-FMK. Cells were then incubated in the absence (Basal) or presence of 1 mM ATP at 
37°C for 24 h. Cells were harvested, and labelled with Annexin-V-FLUOS and 7AAD, and 
the percentage of Annexin-V+/7AAD− (early apoptotic; left panels) or Annexin-V+/7AAD+ 
(late apoptotic; right panels) cells analysed by flow cytometry. (B) H2DCFDA-loaded MEL 
cells in NaCl medium or complete culture medium (CC) were incubated in the absence (Basal) 
or presence of 1 mM ATP at 37°C for 15 min. Incubations were stopped by addition of 
MgCl2 medium and centrifugation, and the mean fluorescence intensity (MFI) of DCF (ROS 
formation) was determined by flow cytometry. (E) MEL cells in NaCl medium were 
pre-incubated at 37°C for 30 min in the presence of DMSO or 20 µM SB202190 (left panel), 
DMSO or 20 µM SB203580 (centre panel), or DMSO or 20 µM Z-VAD-FMK (right panel). 
Ethidium+ (25 µM) was added and cells were incubated in the absence (Basal) or presence of 
1 mM ATP at 37°C for 15 min. Incubations were stopped by addition of MgCl2 medium and 
centrifugation, and the mean fluorescence intensity (MFI) of ethidium+ uptake (pore 
formation) analysed by flow cytometry. (A-E) Results are mean ± SD (n = 3); *P < 0.05, **P 
< 0.01 compared to corresponding Basal; †P < 0.05, ††P < 0.01 compared to ATP alone. 
 
Fig. 5 P2X7 activation induces p38 MAPK and caspase activation in MEL cells. (A) MEL 
cells in complete culture medium were pre-incubated in the absence or presence of 10 µM 
A-438079 at 37°C for 15 min, and then in the absence or presence of 1 mM ATP at 37°C for 
5 min. Whole lysates of MEL cells were then separated by SDS-PAGE, transferred to 
	  
	   30	  
nitrocellulose membrane and probed with (top panel) anti-phospho-p38 (p-p38) and (bottom 
panel) anti-p38 (p38) antibodies. (B) MEL cells in complete culture medium were 
pre-incubated in the absence (Control) or presence of 10 µM A-438079 at 37°C for 15 min, 
and then in the absence (Basal) or presence of 1 mM ATP at 37°C for 6 h. Cells were then 
incubated with FITC-VAD-FMK at 37°C for 1 h and 7AAD for the final 5 min, and the 
percentage of FITC+/7AAD+ (caspase activated) cells analysed by flow cytometry. Results 
are mean ± SD (n = 3); **P < 0.01 compared to corresponding Basal; ††P < 0.01 compared to 
ATP alone. 
